These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7043320)

  • 1. [Current findings in progressive systemic sclerosis].
    Zanussi C; Ortolani C; Pastorello E; Riboldi PS; Sabbadini MG
    Minerva Med; 1982 Apr; 73(18):1189-200. PubMed ID: 7043320
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred.
    Soppi E; Lehtonen A; Toivanen A
    Clin Exp Immunol; 1982 Nov; 50(2):275-82. PubMed ID: 6217932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryoglobulinemia and circulating immune complexes in progressive systemic sclerosis.
    Malaviya AN; Rajagopalan P; Gupta S; Taneja RL
    Indian J Med Res; 1980 Sep; 72():359-64. PubMed ID: 6970181
    [No Abstract]   [Full Text] [Related]  

  • 4. Idiopathic portal hypertension associated with progressive systemic sclerosis.
    Umeyama K; Yui S; Fukamizu A; Yoshikawa K; Yamashita T
    Am J Gastroenterol; 1982 Sep; 77(9):645-8. PubMed ID: 7114027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progressive systemic sclerosis. Chromosomal instability nd its correlation with the presence of autoantibodies].
    Martínez-Cordero E; Reyes López PA; Vergara MD; Morán Ramón L; Benavides de Larraza G; Kofman de Alfaro S; Katona Salgo G
    Rev Invest Clin; 1985; 37(4):329-35. PubMed ID: 3879371
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticentromere antibody and primary pulmonary hypertension.
    Seibold JR; Trontell MC
    J Rheumatol; 1982; 9(4):607-9. PubMed ID: 6752406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic findings in progressive scleroderma--diagnostic and nosologic significance].
    Sönnichsen N; Brenke A; Barthelmes H; Albrecht-Nebe H; Diezel W
    Dermatol Monatsschr; 1983 Jun; 169(6):385-93. PubMed ID: 6603989
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical features of systemic sclerosis.
    Al-Adhadh RN; Al-Sayed TA
    Saudi Med J; 2001 Apr; 22(4):333-6. PubMed ID: 11331491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of progressive systemic sclerosis.
    Haustein UF; Herrmann K; Böhme HJ
    Int J Dermatol; 1986 Jun; 25(5):286-93. PubMed ID: 3522447
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases.
    Poirier TJ; Rankin GB
    Am J Gastroenterol; 1972 Jul; 58(1):30-44. PubMed ID: 4537959
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
    Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M;
    Ann Rheum Dis; 2011 Mar; 70(3):476-81. PubMed ID: 21081523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration.
    Furst DE; Clements PJ; Saab M; Sterz MG; Paulus HE
    Ann Rheum Dis; 1984 Dec; 43(6):794-801. PubMed ID: 6335385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
    Doran M; Wordsworth P; Bresnihan B; Fitzgerald O
    J Rheumatol; 2001 Apr; 28(4):921-2. PubMed ID: 11327280
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progressive systemic sclerosis without cutaneous involvement].
    Pereira RM; Missi SM; Thomazini E; Yoshinari NH
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):144-7. PubMed ID: 3494294
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmunity, immunoglobulins and T lymphocyte population in old age.
    Prieto Valtuena J; Gonzalez Guilabert MI; Del Pozo Perez MA; Del Pozo Crespo F; Velasco Alonso R
    Biomedicine; 1973 Jul; 19(7):301-3. PubMed ID: 4544644
    [No Abstract]   [Full Text] [Related]  

  • 16. [Classification of progressive systemic scleroderma].
    Holzmann H; Sollberg S; Altmeyer P
    Hautarzt; 1987 May; 38(5):253-7. PubMed ID: 3497136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of progressive systemic sclerosis.
    Postlethwaite AE; Kang AH
    J Lab Clin Med; 1984 Apr; 103(4):506-10. PubMed ID: 6607964
    [No Abstract]   [Full Text] [Related]  

  • 18. Progression of childhood linear scleroderma to fatal systemic sclerosis.
    Mayorquin FJ; McCurley TL; Levernier JE; Myers LK; Becker JA; Graham TP; Pincus T
    J Rheumatol; 1994 Oct; 21(10):1955-7. PubMed ID: 7837166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-immunological characteristics of the course of systemic scleroderma].
    Musaev SK; Speranskiĭ AI
    Ter Arkh; 1984; 56(5):42-5. PubMed ID: 6611599
    [No Abstract]   [Full Text] [Related]  

  • 20. Red flags in scleroderma.
    Li Q; Sahhar J; Littlejohn G
    Aust Fam Physician; 2008 Oct; 37(10):831-4. PubMed ID: 19002303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.